Literature DB >> 17194762

D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum.

Asim J Rashid1, Christopher H So, Michael M C Kong, Teresa Furtak, Mufida El-Ghundi, Regina Cheng, Brian F O'Dowd, Susan R George.   

Abstract

We demonstrate a heteromeric D1-D2 dopamine receptor signaling complex in brain that is coupled to Gq/11 and requires agonist binding to both receptors for G protein activation and intracellular calcium release. The D1 agonist SKF83959 was identified as a specific agonist for the heteromer that activated Gq/11 by functioning as a full agonist for the D1 receptor and a high-affinity partial agonist for a pertussis toxin-resistant D2 receptor within the complex. We provide evidence that the D1-D2 signaling complex can be more readily detected in mice that are 8 months in age compared with animals that are 3 months old, suggesting that calcium signaling through the D1-D2 dopamine receptor complex is relevant for function in the postadolescent brain. Activation of Gq/11 through the heteromer increases levels of calcium/calmodulin-dependent protein kinase IIalpha in the nucleus accumbens, unlike activation of Gs/olf-coupled D1 receptors, indicating a mechanism by which D1-D2 dopamine receptor complexes may contribute to synaptic plasticity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17194762      PMCID: PMC1766439          DOI: 10.1073/pnas.0604049104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

Review 1.  Dopamine receptor signaling.

Authors:  Kim A Neve; Jeremy K Seamans; Heather Trantham-Davidson
Journal:  J Recept Signal Transduct Res       Date:  2004-08       Impact factor: 2.092

Review 2.  Neuronal calcium signaling.

Authors:  M J Berridge
Journal:  Neuron       Date:  1998-07       Impact factor: 17.173

3.  Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.

Authors:  P Seeman; H B Niznik; H C Guan; G Booth; C Ulpian
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

4.  Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens.

Authors:  M H Teicher; S L Andersen; J C Hostetter
Journal:  Brain Res Dev Brain Res       Date:  1995-11-21

5.  Calcium-mediated second messengers modulate the expression of behavioral sensitization to cocaine.

Authors:  R C Pierce; E A Quick; D C Reeder; Z R Morgan; P W Kalivas
Journal:  J Pharmacol Exp Ther       Date:  1998-09       Impact factor: 4.030

Review 6.  Calcium signaling dysfunction in schizophrenia: a unifying approach.

Authors:  Michael S Lidow
Journal:  Brain Res Brain Res Rev       Date:  2003-09

7.  A novel Galphaq/11-selective inhibitor.

Authors:  Jun Takasaki; Tetsu Saito; Masatoshi Taniguchi; Tomihisa Kawasaki; Yumiko Moritani; Kazumi Hayashi; Masato Kobori
Journal:  J Biol Chem       Date:  2004-08-31       Impact factor: 5.157

8.  Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation.

Authors:  H Y Wang; A S Undie; E Friedman
Journal:  Mol Pharmacol       Date:  1995-12       Impact factor: 4.436

9.  Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal.

Authors:  Samuel P Lee; Christopher H So; Asim J Rashid; George Varghese; Regina Cheng; A José Lança; Brian F O'Dowd; Susan R George
Journal:  J Biol Chem       Date:  2004-05-24       Impact factor: 5.157

10.  Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain.

Authors:  A S Undie; J Weinstock; H M Sarau; E Friedman
Journal:  J Neurochem       Date:  1994-05       Impact factor: 5.372

View more
  190 in total

1.  Coexpressed D1- and D2-like dopamine receptors antagonistically modulate acetylcholine release in Caenorhabditis elegans.

Authors:  Andrew T Allen; Kathryn N Maher; Khursheed A Wani; Katherine E Betts; Daniel L Chase
Journal:  Genetics       Date:  2011-04-21       Impact factor: 4.562

Review 2.  Novel dopamine D2 receptor signaling through proteins interacting with the third cytoplasmic loop.

Authors:  Kohji Fukunaga; Norifumi Shioda
Journal:  Mol Neurobiol       Date:  2011-12-20       Impact factor: 5.590

3.  Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal.

Authors:  Anna K Radke; Jonathan C Gewirtz
Journal:  Neuropsychopharmacology       Date:  2012-06-13       Impact factor: 7.853

Review 4.  Striatal mechanisms underlying movement, reinforcement, and punishment.

Authors:  Alexxai V Kravitz; Anatol C Kreitzer
Journal:  Physiology (Bethesda)       Date:  2012-06

Review 5.  Functional selectivity in GPCR heterocomplexes.

Authors:  J González-Maeso; S C Sealfon
Journal:  Mini Rev Med Chem       Date:  2012-08       Impact factor: 3.862

Review 6.  On the expanding terminology in the GPCR field: the meaning of receptor mosaics and receptor heteromers.

Authors:  Luigi F Agnati; Diego Guidolin; Jean Pierre Vilardaga; Francisco Ciruela; Kjell Fuxe
Journal:  J Recept Signal Transduct Res       Date:  2010-10       Impact factor: 2.092

Review 7.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

Review 8.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

9.  Formation of mu-/kappa-opioid receptor heterodimer is sex-dependent and mediates female-specific opioid analgesia.

Authors:  Sumita Chakrabarti; Nai-Jiang Liu; Alan R Gintzler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

10.  Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers.

Authors:  Christopher H So; Vaneeta Verma; Mohammad Alijaniaram; Regina Cheng; Asim J Rashid; Brian F O'Dowd; Susan R George
Journal:  Mol Pharmacol       Date:  2009-01-26       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.